Serum IgM antibody response to Clostridioides difficile polysaccharide PS-II vaccination in pony foals.

The research article deals with the exploration of a potential vaccination for Clostridioides difficile, a bacteria associated with colitis in horses, focusing specifically on the antibody responses in foals.

Research Context

• This research was conducted against the backdrop of the pressing need to prevent colonization by Clostridioides difficile, a bacterium responsible for colitis in foals and mature horses.
• Clostridioides difficile exposes specific polysaccharides, named PS-I, PS-II and PS-III, on its cell surface that could potentially be targets for a vaccine.
• Of the polysaccharides exposed by the bacterium, the researchers focused on PS-II, a hexasaccharide phosphate found in all examined Clostridioides difficile ribotypes.

Study Methodology

• To evaluate the reactogenicity and immunogenicity of C. difficile PS-II in foals, the researchers injected three-to-four-month-old foals with either 100 ľg/dose or 500 ľg/dose of purified PS-II antigen combined with an aluminium hydroxide adjuvant.
• These foals were vaccinated three times at three-week intervals. A placebo preparation (containing the adjuvant only) was given to two control foals.

Results and Findings

• No adverse reactions like injection site swelling, pain, or fever were observed after the vaccination.
• IgM immune responses were induced by the vaccination. Two of the three foals receiving 100 ľg/dose, and all three foals receiving 500 ľg/dose of PS-II, showed increases in serum IgM antibodies.
• No control foals that received the placebo showed IgM responses to PS-II.
• The researchers observed a trend towards a higher response rate in foals receiving 500 ľg PS-II one week after second vaccination compared to control foals.
• There was also a trend towards higher concentrations of serum IgM antibodies in foals receiving the higher (500 ľg) dose of PS-II.

Conclusions and Implications

• The study concludes that no adverse reactions were observed following vaccination with PS-II in foals, validating the reactogenicity and immunogenicity of the PS-II antigen.
• The induced Serum IgM immune responses indicate that a polysaccharide-based vaccine for C. difficile in horses deserves further investigation.